UBS Upgrades Johnson & Johnson to Buy, Announces $180 Price Target
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Danielle Antalffy upgraded Johnson & Johnson (NYSE:JNJ) from Neutral to Buy and set a price target of $180.
December 01, 2023 | 11:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS upgraded Johnson & Johnson to Buy from Neutral and set a price target of $180, indicating a positive outlook on the stock.
An upgrade from a reputable analyst like UBS can lead to increased investor confidence and potential stock price appreciation. The new price target of $180 suggests a significant upside from the current trading price, which may attract more buyers in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100